Literature DB >> 23645776

Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.

Goro Kasuya1, Kazuhiko Ogawa, Shiro Iraha, Yutaka Nagai, Makoto Hirakawa, Takafumi Toita, Yasumasa Kakinohana, Wataru Kudaka, Morihiko Inamine, Takuro Ariga, Yoichi Aoki, Sadayuki Murayama.   

Abstract

AIM: To retrospectively analyze the treatment results of postoperative radiotherapy (PORT) in patients with early-stage uterine cervical cancer. PATIENTS AND METHODS: Records of 141 patients with stage IB-IIB uterine cervical cancer treated with PORT from 1985 to 2004 were retrospectively reviewed. The majority of patients received whole-pelvic radiotherapy with antero-posterior fields, and the total radiation doses ranged from 10.8-60 Gy (median: 50.4 Gy). The median follow-up of all 141 patients was 106 months (range: 0.8-273.7 months).
RESULTS: Multivariate analysis revealed that positive lymph node status (p=0.001) and histological type (p=0.015) were independent prognostic factors for overall survival. The group with three or more involved lymph nodes was significantly more likely to have extra-pelvic recurrence when compared with the groups with no (p=0.006) and up to two lymph nodes (p=0.024), respectively.
CONCLUSION: PORT yielded excellent pelvic control rates for early-stage uterine cervical cancer. Lymph node status and histological type were significant prognostic factors for overall survival of patients with these tumors.

Entities:  

Keywords:  Radiation therapy; postoperative radiotherapy; uterine cervical cancer

Mesh:

Year:  2013        PMID: 23645776

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Risk Stratification Based on Metastatic Pelvic Lymph Node Status in Stage IIIC1p Cervical Cancer.

Authors:  Anyang Li; Luhui Wang; Qi Jiang; Wenlie Wu; Baoyou Huang; Haiyan Zhu
Journal:  Cancer Manag Res       Date:  2020-07-28       Impact factor: 3.989

2.  The evaluation of older patients with cervical cancer.

Authors:  Ying Gao; Jin-lu Ma; Fei Gao; Li-ping Song
Journal:  Clin Interv Aging       Date:  2013-06-25       Impact factor: 4.458

3.  Incorporation of the number of positive lymph nodes leads to better prognostic discrimination of node-positive early stage cervical cancer.

Authors:  Juan Zhou; San-Gang Wu; Jia-Yuan Sun; Xu-Lin Liao; Feng-Yan Li; Huan-Xin Lin; Li-Chao Yang; Zhen-Yu He
Journal:  Oncotarget       Date:  2017-04-18

4.  Mind the gaps: a qualitative study of perceptions of healthcare professionals on challenges and proposed remedies for cervical cancer help-seeking in post conflict northern Uganda.

Authors:  Amos D Mwaka; Henry R Wabinga; Harriet Mayanja-Kizza
Journal:  BMC Fam Pract       Date:  2013-12-17       Impact factor: 2.497

5.  Outcome and prognostic factors in cervical cancer patients treated with surgery and concurrent chemoradiotherapy: a retrospective study.

Authors:  Yan-Mei Liu; Ling-Qin Ni; Sai-Sai Wang; Qian-Ling Lv; Wei-Jun Chen; Shen-Peng Ying
Journal:  World J Surg Oncol       Date:  2018-01-29       Impact factor: 2.754

6.  The impact of examined lymph node count on survival in squamous cell carcinoma and adenocarcinoma of the uterine cervix.

Authors:  Juan Zhou; Wen-Wen Zhang; San-Gang Wu; Zhen-Yu He; Jia-Yuan Sun; Yan Wang; Qiong-Hua Chen
Journal:  Cancer Manag Res       Date:  2017-07-18       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.